熱門資訊> 正文

Artelo Biosciences启动公开募股;股价下跌10%

2025-09-04 04:50

Artelo Biosciences (NASDAQ:ARTL) has commenced an underwritten public offering of common stock and/or pre-funded warrants.
All securities in the offering will be sold by the company itself.
The size, pricing, and terms of the offering are yet to be determined.
Proceeds are expected to support the company’s clinical-stage programs targeting cancer, pain, and neurological conditions.
ARTL shares down 9.9% post-market on Wednesday.
Source: Press release

More on AtkinsRéalis Group Inc.

AtkinsRéalis Group Inc. 2025 Q2 - Results - Earnings Call Presentation
AtkinsRéalis Group Inc. Q2 2025 Earnings Call Transcript
AtkinsRéalis to repurchase 7M shares from La Caisse
Historical earnings data for AtkinsRéalis Group Inc.
Dividend scorecard for AtkinsRéalis Group Inc.

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。